Organized by
melanoma
in collaboration with
sitc_smallino
under the auspices of
2023 logo AIOM con scritta
LOGO PASCALE

IMMUNOTHERAPY BRIDGE
December 1st-2nd, 2021

Wednesday, Dec 1st, 2021

10:30 am

Introduction and objectives
Paolo A. Ascierto

SITC SESSION
LESSONS LEARNED FROM CELL THERAPIES
Chairpersons: Patrick Hwu, Bernard A. Fox

10:40 am

CAR-T
Chrystal Paulos

10:55 am

Targeting solid malignancies with ‘public’ neoantigen-specific T cell receptors

Christopher Klebanoff

11:10 am

Harnessing the power of a natural killer: bringing NK cells to immuno-oncology
Tamara Laskowski

11:25 am

Understanding resistance to develop better CAR T immunotherapies
Marco Ruella

11:40 am

Best of SITC 2021 for clinical development and trials
Paolo A. Ascierto

11:55 am

Discussion

12:25 am

LECTURE – Immunotherapy in Renal Cell Carcinoma: update and new perspectives
Chairpersons: Paolo A. Ascierto
TBD

12:55 pm

Lunch**

01:45 pm

SYMPOSIUM – Combinations therapy across cancers
Chairperson: Paolo A. Ascierto
NSCLC, Cesare Gridelli – RCC, Camillo Porta – Melanoma, Paolo A. Ascierto

SESSION 2
TRENDS IN IMMUNOTHERAPY
Chairpersons: John B. Haanen, Sandro Pignata

02:35 pm

Integrating Head and Neck Cancer Immunotherapy into Locally Advanced Treatment
Robert Ferris

02:50 pm

Pancreatic Cancer
Elizabeth Jaffee

03:05 pm

Kidney Cancer
Sergio Bracarda

03:20 pm

GI cancer
Antonio Avallone

03:35 pm

Implications of the Tumor Microenvironment for Breast Cancer Immunotherapy
Leisha A. Emens

03:50 pm

Ovarian Cancer
Takemasa Tsuji*

04:05 pm

Coffee Break**

04:20 pm

PDI-blockade for Hodgkin Lymphoma: results, challenges and opportunities
Antonio Pinto

04:35 pm

Lecture: Merkel Cell Carcinoma
Paolo A. Ascierto

04:50 pm

Discussion

GREAT DEBATE SESSION
Chairpersons: Paolo A. Ascierto, Bernard A. Fox, Patrick Hwu, Igor Puzanov

05:20 pm

Have B-cells a therapeutic role in the response to cancer immunotherapy? Yes or No
Wolf Fridman, Tullia Bruno

05:50 pm

Discussion

06:00 pm

Intralesional therapy: oncolytic virus VS other specific immune modulators
Igor Puzanov, Omid Hamid*

06:30 pm

Discussion

06:40 pm

Do early surrogates correlate with long-term overall survival? Yes or No
Michael A. Postow, Jeffrey Sosman

07:10 pm

Discussion